COLL vs EG · P/E 17, rev $181.9M vs P/E 17, rev $17.28B
Collegium Pharmaceutical Inc (COLL) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the COLL and EG stock pages for the full models.
Not investment advice.